clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT03828422 |
P582 | end time | 2019-07-01 | |
P1050 | medical condition | atherosclerosis | Q12252367 |
P2899 | minimum age | 18 | |
P1132 | number of participants | 82 | |
P4844 | research intervention | calcium oxalate | Q412399 |
P580 | start time | 2014-01-01 | |
P8363 | study type | observational study | Q818574 |
P1476 | title | Arterial Function and Atherosclerosis in Patients With JAK2 V167F Positive Essential Thrombocythemia |